Catalyst Wire Dossier Catalyst Wire Dossier

HADLIMA

ADALIMUMAB-BWWD · Organon LLC
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for HADLIMA, covering 2019-07-23 to 2025-10-17. Get the full timeline:

Most recent: FDA Approved: HADLIMA — Supplemental Application (Organon LLC)

See pricing